CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Shipment of Proprietary Dry Herb Inhalers for Use in Pilot Program

June 23, 2021 10:56:20

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has  completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers. The shipment was sent to Medicann in Jersey, the largest of the Channel Islands, located between England and France. A premier cannabis-specialized clinic, Medicann plans to use the inhalers for use in a pilot program designed to collect patient feedback regarding consumption of cannabis strains that are available on the island. According to the announcement, the parties will also be working on defining an exclusive, definitive supply and distribution agreement that would name Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies,” said RYAH Group CEO Gregory Wagner in the press release. “RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens.”

To view the full press release, visit

About RYAH Group Inc.

RYAH Group is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong IP (“IP”) portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.